Inno Gene SA

  • Market Cap: Micro Cap
  • Industry: Miscellaneous Commercial Services
  • ISIN: PLINNGN00015
PLN
2.32
-0.29 (-11.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.25 k

Shareholding (Jun 2023)

FII

0.00%

Held by 0 FIIs

DII

0

Held by 0 DIIs

Promoter

41.19%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROE of 58.07%

 
2

The company has declared positive results in Dec'2024 after 10 consecutive negative quarters

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous Commercial Services

stock-summary
Market cap

PLN 94 Million (Micro Cap)

stock-summary
P/E

49.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.57

stock-summary
Return on Equity

23.44%

stock-summary
Price to Book

11.38

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-34.65%
0%
-34.65%
6 Months
-16.85%
0%
-16.85%
1 Year
-16.25%
0%
-16.25%
2 Years
-59.93%
0%
-59.93%
3 Years
-75.58%
0%
-75.58%
4 Years
-89.06%
0%
-89.06%
5 Years
-8.66%
0%
-8.66%

Inno Gene SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.57%
EBIT Growth (5y)
27.35%
EBIT to Interest (avg)
2.94
Debt to EBITDA (avg)
0.54
Net Debt to Equity (avg)
0.76
Sales to Capital Employed (avg)
0.69
Tax Ratio
0.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
70.37%
ROE (avg)
58.07%
Valuation key factors
Factor
Value
P/E Ratio
49
Industry P/E
Price to Book Value
11.38
EV to EBIT
49.65
EV to EBITDA
49.15
EV to Capital Employed
7.61
EV to Sales
29.90
PEG Ratio
0.40
Dividend Yield
NA
ROCE (Latest)
15.33%
ROE (Latest)
23.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -96.77% vs 3,000.00% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -103.45% vs 1,066.67% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "3.10",
          "chgp": "-96.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.00",
          "val2": "3.00",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.10",
          "val2": "2.90",
          "chgp": "-103.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-873.20%",
          "val2": "957.90%",
          "chgp": "-183.11%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 200.00% vs -93.29% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 130.65% vs -2,166.67% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.30",
          "val2": "1.10",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.10",
          "val2": "-2.90",
          "chgp": "172.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.90",
          "val2": "-6.20",
          "chgp": "130.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "637.30%",
          "val2": "-2,676.40%",
          "chgp": "331.37%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
0.10
3.10
-96.77%
Operating Profit (PBDIT) excl Other Income
-0.00
3.00
-100.00%
Interest
0.00
0.00
Exceptional Items
-0.00
0.00
Consolidate Net Profit
-0.10
2.90
-103.45%
Operating Profit Margin (Excl OI)
-873.20%
957.90%
-183.11%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is -96.77% vs 3,000.00% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is -103.45% vs 1,066.67% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3.30
1.10
200.00%
Operating Profit (PBDIT) excl Other Income
2.10
-2.90
172.41%
Interest
0.00
0.00
Exceptional Items
0.00
-1.30
100.00%
Consolidate Net Profit
1.90
-6.20
130.65%
Operating Profit Margin (Excl OI)
637.30%
-2,676.40%
331.37%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 200.00% vs -93.29% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 130.65% vs -2,166.67% in Dec 2023

stock-summaryCompany CV
About Inno Gene SA stock-summary
stock-summary
Inno Gene SA
Miscellaneous Commercial Services
Inno-Gene SA is a Poland-based holding company engaged in management of a portfolio of companies active in life-science sector through the technology, research and development. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
Company Coordinates stock-summary
Company Details
Ul. Sciegiennego 20 , POZNAN None : 60-128
stock-summary
Tel: 48 61 646858548 575 896041
stock-summary
Registrar Details